Related references
Note: Only part of the references are listed.Contaminating tumour cells in autologous PBSC grafts do not influence survival or relapse following transplant for multiple myeloma or B-cell non-Hodgkin's lymphoma
J. Ho et al.
BONE MARROW TRANSPLANTATION (2009)
Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma
H. G. Kopp et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Klaus Pantel et al.
NATURE REVIEWS CANCER (2008)
AMD3100 plus G-CSF can successfully mobilize CD34+cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data
G. Calandra et al.
BONE MARROW TRANSPLANTATION (2008)
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+cell selection: long term follow-up of an EBMT phase III randomized study
Jean-Henri Bourhis et al.
HAEMATOLOGICA (2007)
Efficient mobilization of peripheral blood stem cells following CAD chemotherapyand a single dose of pegylated G-CSF in patients with multiple myeloma
S. Fruehauf et al.
BONE MARROW TRANSPLANTATION (2007)
Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression
Swati Biswas et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics
Stefan Fruehauf et al.
EXPERIMENTAL HEMATOLOGY (2006)
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
N Flomenberg et al.
BLOOD (2005)
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
HE Broxmeyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist
WC Liles et al.
TRANSFUSION (2005)
Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy
A Anagnostopoulos et al.
BONE MARROW TRANSPLANTATION (2004)
What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?
AP Jillella et al.
STEM CELLS AND DEVELOPMENT (2004)
Infused CD34+ cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy
AK Blystad et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
It's moving day: Factors affecting peripheral blood stem mobilization and strategies for improvement
S Fruehauf et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Share Paper
